Differential effects of short-acting β2-agonists on human granulocyte functions

International Archives of Allergy and Immunology

Volumn 139, Issue 1, 2005, Pages 1-8

  Yasui, Kozo ^a   Kobayashi, Norimoto ^a   Yamazaki, Takashi ^a   Agematsu, Kazunaga ^a   Matsuzaki, Satoshi ^a   Nakata, Setsuko ^a   Baba, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 Adrenergic agonists; Airway inflammation; Eosinophil; Neutrophil; Superoxide anion production

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROCATEROL; SALBUTAMOL; SHORT ACTING DRUG; SUPEROXIDE; TULOBUTEROL; ZYMOSAN;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EOSINOPHIL; GRANULOCYTE FUNCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUTROPHIL; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CELL DEGRANULATION; DEPRESSION, CHEMICAL; EOSINOPHILS; GRANULOCYTES; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEROXIDASE; PROCATEROL; SUPEROXIDES; TERBUTALINE;

EID: 30044439403     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089516     Document Type: Article

References (36)

1. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage fluid in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-69.
2. Barnes PJ: New concepts in pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-1026.
3. Bousquet J, Jeffery PK, Busse W, Johnson M, Vinola AM: Asthma: from bronchoconstriction to airway inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
4. Monteseirin J, Bonilla I, Camacho MJ, Chacon P, Vega A, Chaparro A, Conde J, Sobrino F: Specific allergens enhance elastase release in stimulated neutrophils from asthmatic patients. Int Arch Allergy Immunol 2003;131:174-181.
5. Yukawa T, Ukena D, Kroegel C, Chanez P, Dent G, Chung KF, Barnes PJ: Beta 2-adrenergic receptors on eosinophils: binding and functional studies. Am Rev Respir Dis 1990;141:1446-1452.
6. Barnes PJ: Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995;152:838-860.
7. Hanania NA, Sharafkhaneh A, Barber R, Dickey BF: Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med 2002;165:1353-1358.
8. Whelan CJ, Johnson M: Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 1992;105:831-838.
9. 4 by human eosinophils. Eur Respir J 1996;22:S141-S145.
10. Yamazaki M, Matsuoka T, Yasui K, Komiyama A, Akabane T: Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes. J Allergy Clin Immunol 1989;83:967-972.
11. Hadjokas NE, Crowley JJ, Bayer CR, Nielson CP: Beta-adrenergic regulation of the eosinophil respiratory burst as detected by lucigenin-dependent luminescence. J Allergy Clin Immunol 1995;95:735-741.
12. Ottonello L, Morone P, Dapino P, Dallegri F: Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils. Clin Exp Immunol 1996;106:97-102.
13. Mirza ZN, Kato M, Kimura H, Tachibana A, Fujiu T, Suzuki M, Mochizuki H, Tokuyama K, Morikawa A: Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and -independent mechanisms. Ann Allergy Asthma Immunol 2002;88:494-500.
14. Tachibana A, Kato M, Kimura H, Fujiu T, Suzuki M, Morikawa A: Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor- independent actions. Clin Exp Immunol 2002;130:415-423.
15. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - An integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
16. Ezeamuzie CI, al-Hage M: Differential effects of salbutamol and salmeterol on human eosinophil responses. J Pharmacol Exp Ther 1998;284:25-31.
17. Yasui K, Yamazaki M, Miyabayashi M, Tsuno T, Komiyama A: Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor: distinct from the pathway for superoxide anion production. J Immunol 1994;152:5922-5929.
18. Cohen HJ, Chovaniec ME: Superoxide generation by digitonin-stimulated guinea pig granulocytes. J Clin Invest 1978;61:1081-1088.
19. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A: Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 1997;100:1677-1684.
20. Kume H, Kondo M, Ito Y, Suzuki R, Yamaki K, Takagi K: Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function. Clin Exp Pharmacol Physiol 2002;29:1076-1083.
21. Kume H: Clinical use of beta2-adrenergic receptor agonists based on their intrinsic efficacy. Allergol Int 2005;54:89-97.
22. Di Lorenzo G, Morici G, Norrito F, Mansueto P, Melluso M, D'Ambrosio PF, Sangiorgi GB: Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics. Clin Exp Allergy 1995;25:951-956.
23. O'Dowd YM, El-Benna J, Perianin A, Newsholme P: Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of phospholipase A2 activity but not p47phox phosphorylation and translocation. Biochem Pharmacol 2004;67:183-190.
24. Sha'afi RI, Molski TFP: Activation of the neutrophil. Prog Allergy 1988;42:1-64.
25. Koyama S, Sato E, Masubuchi T, Takamizawa A, Kubo K, Nagai S, Isumi T: Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity. Eur Respir J 1999;14:767-775.
26. Yasui K, Agematsu K, Shinozaki K, Hokibara S, Nagumo H, Yamada S, Kobayashi N, Komiyama A: Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions. J Leukoc Biol 2000;68:194-200.
27. Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T: Modulation of interleukin-6 by beta2-adrenoceptor in endotoxin-stimulated renal macrophage cells. Kidney Int 1999;56:839-849.
28. Rivkin I, Becker EL: Effect of exogenous cyclic AMP and other adenine nucleotides on neutrophil chemotaxis and motility. Int Arch Allergy Appl Immunol 1976;50:95-102.
29. Hanania NA, Moore RH: Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy 2004;3:271-277.
30. Nielson CP: Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol 1987;139:2392-2397.
31. Douwes J, Gibson P, Pekkanen J, Pearce N: Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-648.
32. Teran LM, Johnston SL, Schroder JM, Church MK, Holgate ST: Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997;155:1362-1366.
33. Yasui K, Kanda H, Iwanami T, Komiyama A: Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation. Eur Respir J 2003;22:739-742.
34. Ca channels in human trachealis. Am J Respir Crit Care Med 1999;159:452-460.
35. IIkura Y, Matsumoto T, Fujita K, Otsuka T, Sakamoto Y, Yun SK, Saito H, Obata T, Akasawa A, Capulong MC, Sakaguchi N, Oya Y, Tahara K, Tachimoto H, Kawahara H, Koya N: Continuous isoproterenol inhalation therapy in children with severe asthmatic attack. Int Arch Allergy Immunol 1997;113:370-372.
36. Nishimura H, Tokuyama K, Arakawa H, Ohki Y, Sato A, Kato M, Mochizuki H, Morikawa A: Airway responsiveness and airway remodeling after chronic exposure to procaterol and fenoterol in guinea pigs in vivo. Int Arch Allergy Immunol 2002;129:320-326.